|
CN111701600A
|
|
Catalyst for preparing 1-bromo-3, 5-dimethyl adamantane and application thereof
|
|
CN111606826A
|
|
Preparation method of edoxaban intermediate
|
|
CN111205265A
|
|
Preparation method of 2- (4-fluorophenyl) -5- [ (5-bromo-2-methylphenyl) methyl ] thiophene
|
|
CN110586187A
|
|
Supported phosphotungstic acid catalyst, and preparation method and application thereof
|
|
CN110563627A
|
|
Preparation method of (S) -1- (2-chloroacetyl) pyrrolidine-2-carbonitrile
|
|
CN105175337A
|
|
Preparation method of 1-(3-methyl-1-phenyl-1H-pyrazol-5-yl) piperazine
|
|
CN105085510A
|
|
Preparation method of (S)-4-oxo-2-(thiazolidine-3-carbonyl) pyrrolidone-1-carboxylic acid tert-butyl ester
|
|
CN105085469A
|
|
Preparation method of 5-chlorothienyl-2-carboxylic acid
|
|
CN105037245A
|
|
Saxagliptin midbody preparing method
|
|
CN104987320A
|
|
Preparation method of canagliflozin intermediates
|
|
CN105130879A
|
|
Preparation method of (R)-3-Boc-aminopiperidine
|
|
CN104961711A
|
|
Preparation method of (S)-3-hydroxytetrahydrofuran and (R)-3-hydroxytetrahydrofuran
|
|
CN103819394A
|
|
Method for synthesizing 4-pyridylaldehyde by catalytic oxidation
|
|
CN103787990A
|
|
Preparation method of 5-methylpyrazine-2-carboxylic acid
|
|
CN104860845A
|
|
Montelukast sodium side chain key intermediate synthesis method
|
|
CN104844494A
|
|
Vildagliptin preparation method
|
